Literature DB >> 16830282

A case of dyskeratosis congenita with portal hypertension associated with jugular venous anomaly.

Yusuf Yazgan1, Levent Demirtürk, Melih Ozel, Cinar Başekim.   

Abstract

Dyskeratosis congenita is an unusual inherited disease characterized by the triad of abnormal skin pigmentation, nail dystrophy and mucosal leukoplakia. Bone marrow failure and various abnormalities including genitourinary, pulmonary, skeletal, neurological, ophthalmic, dental and gastrointestinal have been reported. Portal hypertension is an extremely rare manifestation. Although arterio-venous fistulas in the lungs have been reported, gross peripheral vascular abnormality associated with the disease has not been published until now. We describe a case of dyskeratosis congenita with portal hypertension and associated coagulopathy in whom transjugular liver biopsy could not be performed because of a vascular anomaly at the bifurcation of the internal jugular and subclavian veins.

Entities:  

Mesh:

Year:  2006        PMID: 16830282

Source DB:  PubMed          Journal:  Turk J Gastroenterol        ISSN: 1300-4948            Impact factor:   1.852


  3 in total

1.  Liver Transplantation After Bone Marrow Transplantation for End Stage Liver Disease with Severe Hepatopulmonary Syndrome in Dyskeratosis Congenita: A Literature First.

Authors:  Shyam Sunder Mahansaria; Senthil Kumar; Kishore G S Bharathy; Sachin Kumar; Viniyendra Pamecha
Journal:  J Clin Exp Hepatol       Date:  2015-11-12

2.  Liver failure due to hepatic angiosarcoma in an adolescent with dyskeratosis congenita.

Authors:  Timothy S Olson; Elaine S Chan; Michele E Paessler; Kathleen E Sullivan; Christopher N Frantz; Piere Russo; Monica Bessler
Journal:  J Pediatr Hematol Oncol       Date:  2014-05       Impact factor: 1.289

3.  Fatal Hemorrhagic Gastrointestinal Angioectasia after Bone Marrow Transplantation for Dyskeratosis Congenita.

Authors:  Jin Imai; Takayoshi Suzuki; Marie Yoshikawa; Makiko Dekiden; Hirohiko Nakae; Fumio Nakahara; Shingo Tsuda; Hajime Mizukami; Jun Koike; Muneki Igarashi; Hiromasa Yabe; Tetsuya Mine
Journal:  Intern Med       Date:  2016-12-01       Impact factor: 1.271

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.